tiprankstipranks
AnaptysBio Inc (GB:0HFQ)
LSE:0HFQ

AnaptysBio (0HFQ) Income Statement

0 Followers

AnaptysBio Income Statement

Last quarter (Q4 2023), AnaptysBio's total revenue was $9.01M, an increase of 32.27% from the same quarter last year. In Q4, AnaptysBio's net income was $-42.21M. See AnaptysBio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 17.16M$ 17.16M$ 10.29M$ 63.17M$ 75.00M$ 8.00M
Cost of Revenue
------
Gross Profit
$ 17.16M$ 17.16M$ 10.29M$ 63.17M--
Operating Expense
$ 181.57M$ 181.57M$ 125.44M$ -119.99M$ 98.88M$ 115.43M
Operating Income
$ -164.41M$ -164.41M$ -115.15M$ -56.81M$ -23.88M$ -107.43M
Net Non Operating Interest Income Expense
$ 14.54M$ 18.87M$ 7.55M$ -1.07M$ 3.96M$ 9.94M
Other Income Expense
$ 13.75M$ 18.09M$ 21.10M$ -37.00K$ -11.00K$ 1.00K
Pretax Income
$ -163.62M$ -163.62M$ -128.70M$ -57.80M$ -19.93M$ -97.49M
Tax Provision
$ -4.00K$ -4.00K$ 24.00K-$ 0.00$ -152.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -163.62M$ -163.62M$ -128.72M$ -57.85M$ -19.93M$ -97.34M
Basic EPS
$ -6.08$ -6.08$ -4.57$ -2.11$ -0.73$ -3.60
Diluted EPS
$ -6.08$ -6.08$ -4.57$ -2.11$ -0.73$ -3.60
Basic Average Shares
$ 107.70M$ 26.92M$ 28.16M$ 27.43M$ 27.30M$ 27.06M
Diluted Average Shares
$ 107.70M$ 26.92M$ 28.16M$ 27.43M$ 27.30M$ 27.06M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 181.57M$ 181.57M$ -125.44M$ -119.99M$ 98.88M$ 115.43M
Net Income From Continuing And Discontinued Operation
$ -163.62M$ -163.62M$ -128.72M$ -57.85M$ -19.93M$ -97.34M
Normalized Income
$ -103.17M$ -163.63M--$ -19.93M$ -97.34M
Interest Expense
----$ 0.00$ 1.04M
EBIT
$ -163.62M$ -163.62M$ -128.70M$ -57.80M$ -19.93M$ -96.45M
EBITDA
$ -161.25M$ -161.25M$ -126.36M$ -55.71M$ -18.31M$ -95.93M
Currency in USD

AnaptysBio Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis